- Home
- ANVS vs PVL Comparison
ANVS vs PVL Comparison
Compare ANVS & PVL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | ANVS | PVL |
|---|---|---|
| Founded | 2008 | 2011 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Oil & Gas Production |
| Sector | Health Care | Energy |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 53.3M | 57.8M |
| IPO Year | 2020 | N/A |
Fundamental Metrics
Financial Performance| Metric | ANVS | PVL |
|---|---|---|
| Price | $4.55 | $1.87 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $13.50 | N/A |
| AVG Volume (30 Days) | ★ 3.9M | 81.6K |
| Earning Date | 11-12-2025 | 01-01-0001 |
| Dividend Yield | N/A | ★ 19.25% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.06 |
| Revenue | N/A | ★ $3,511,891.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $29.20 |
| Revenue Growth | N/A | ★ 11.77 |
| 52 Week Low | $1.11 | $1.30 |
| 52 Week High | $6.37 | $2.04 |
Technical Indicators
Market Signals| Indicator | ANVS | PVL |
|---|---|---|
| Relative Strength Index (RSI) | 68.85 | 60.52 |
| Support Level | $4.01 | $1.82 |
| Resistance Level | $4.82 | $1.83 |
| Average True Range (ATR) | 0.66 | 0.06 |
| MACD | 0.06 | 0.01 |
| Stochastic Oscillator | 69.78 | 86.67 |
Price Performance
Historical ComparisonAbout ANVS Annovis Bio Inc.
Annovis Bio Inc is a clinical-stage pharmaceutical company focused on developing and commercializing drugs for the treatment of Parkinson's and Alzheimer's diseases and other neurodegenerative diseases. The pipeline products of the company consists of: Buntanetap for chronic neurodegeneration - including AD and PD; ANVS405 for acute neurodegeneration; and ANVS301 for AD.
About PVL Permianville Royalty Trust Trust Units
Permianville Royalty Trust is a statutory trust which holds net profits interests in the profits from the sale of oil and natural gas production from non-operated assets of both conventional properties in the States of Texas, Louisiana, and New Mexico as well as unconventional assets in the Permian and Haynesville basins.